![Jonathan Birchall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Birchall
Corporate Officer/Principal chez
IONIS PHARMACEUTICALS, INC.
Profil
Mr. Jonathan J.
Birchall is a Chief Commercial Officer & Senior Vice President at Ionis Pharmaceuticals, Inc. Mr. Birchall was previously employed as a Chief Commercial Officer by PhaseBio Pharmaceuticals, Inc. and a Vice President & Head-US Thrombolytics Franchise by Genentech, Inc.
Postes actifs de Jonathan Birchall
| Sociétés | Poste | Début |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2023 |
Anciens postes connus de Jonathan Birchall
| Sociétés | Poste | Fin |
|---|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
